Pfizer Technical Analysis



As of date:2/13/2025
PFE stock price:25.64
PFE 50 DMA:25.89
PFE 200 DMA:27.07
PFE MACD (200-50):1.18
PFE RSI:44.78
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)44.78
Extremely
Oversold

Also see:
PFE Market Cap History
PFE Shares Outstanding History
PFE YTD Return

Quotes delayed 20 minutes

Email EnvelopeFree PFE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

UEC Crosses Below Key Moving Average Level
30 minutes ago


DRS Makes Notable Cross Below Critical Moving Average
31 minutes ago


RGC Resources (RGCO) Shares Cross Below 200 DMA
31 minutes ago


Notable Two Hundred Day Moving Average Cross - DY
33 minutes ago


Notable Two Hundred Day Moving Average Cross - WKC
33 minutes ago


ZTR Crosses Below Key Moving Average Level
36 minutes ago


Nexa Resources (NEXA) Shares Enter Oversold Territory
36 minutes ago


LSAK Crosses Above Key Moving Average Level
39 minutes ago


ORN Crosses Below Key Moving Average Level
42 minutes ago


ALLY Crosses Above Key Moving Average Level
42 minutes ago


JKS Crosses Above Key Moving Average Level
44 minutes ago


Acushnet Holdings (GOLF) Shares Cross Below 200 DMA
44 minutes ago


Cadre Holdings (CDRE) Shares Cross Below 200 DMA
45 minutes ago


EMBC Makes Notable Cross Below Critical Moving Average
4 hours, 32 minutes ago


PDD Makes Bullish Cross Above Critical Moving Average
5 hours, 1 minute ago


More Technical Analysis News

PFE Technical AnalysisPFE RSI
Pfizer Inc. is a research-based global biopharmaceutical company. Co. is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak.

When researching a stock like Pfizer, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from PFE Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for PFE stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
PFE DMAPFE MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Pfizer (PFE) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

PODD Technical Analysis
REGN Technical Analysis
RMD Technical Analysis
RVTY Technical Analysis
SOLV Technical Analysis
STE Technical Analysis
SYK Technical Analysis
TECH Technical Analysis
TFX Technical Analysis
TMO Technical Analysis
More Healthcare companies »

 

Pfizer Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2025, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.